← К результатам

Trends Pharmacol Sci · 2020

Rewired Cas9s with Minimal Sequence Constraints.

Trends in pharmacological sciences, 41(7): 429-431 PMID 32416935 DOI 10.1016/j.tips.2020.04.009

Открыть в PubMed ↗ Открыть по DOI ↗

Аннотация

The genome editing toolkit is ever expanding. Although CRISPR-Cas systems can target virtually any gene, single-nucleotide resolution is yet to be achieved. Walton and colleagues engineered nucleases and base editors compatible with every protospacer adjacent motif (PAM) to achieve high-precision targeting. Their findings revealed the striking plasticity of Cas9.

Цитирование